Skip Nav Destination
Issues
June 2010
- Cover Image
- PDF Icon PDF LinkTable of Contents
ISSN 0149-5992
EISSN 1935-5548
In this Issue
Original Research
Clinical Care / Education / Nutrition / Psychosocial Research
Effect of the Look AHEAD Study Intervention on Medication Use and Related Cost to Treat Cardiovascular Disease Risk Factors in Individuals With Type 2 Diabetes
J. Bruce Redmon, MD; Alain G. Bertoni, MD; Stephanie Connelly, MD; Patricia A. Feeney, MA; Stephen P. Glasser, MD; Henry Glick, PHD; Frank Greenway, MD; Louise A. Hesson, MSN; Michael S. Lawlor, PHD; Maria Montez, MSHP; Brenda Montgomery, RN; the Look AHEAD Research Group
Diabetes Care March 2010, Vol.33, 1153-1158. doi:https://doi.org/10.2337/dc09-2090
Executive Functioning, Treatment Adherence, and Glycemic Control in Children With Type 1 Diabetes
Kelly McNally, PHD; Jennifer Rohan, MA; Jennifer Shroff Pendley, PHD; Alan Delamater, PHD; Dennis Drotar, PHD
Diabetes Care March 2010, Vol.33, 1159-1162. doi:https://doi.org/10.2337/dc09-2116
Effect of Ranolazine on A1C and Glucose Levels in Hyperglycemic Patients With Non-ST Elevation Acute Coronary Syndrome
Jeffrey W. Chisholm, PHD; Allison B. Goldfine, MD; Arvinder K. Dhalla, PHD; Eugene Braunwald, MD; David A. Morrow, MD, MPH; Ewa Karwatowska-Prokopczuk, MD; Luiz Belardinelli, MD
Diabetes Care March 2010, Vol.33, 1163-1168. doi:https://doi.org/10.2337/dc09-2334
Health-Related Quality of Life, Treatment Satisfaction, and Costs Associated With Intraperitoneal Versus Subcutaneous Insulin Administration in Type 1 Diabetes: A randomized controlled trial
Susan J. Logtenberg, MD, PHD; Nanne Kleefstra, MD; Sebastiaan T. Houweling, MD, PHD; Klaas H. Groenier, PHD; Reinold O. Gans, MD, PHD; Henk J. Bilo, MD, PHD, FRCP
Diabetes Care February 2010, Vol.33, 1169-1172. doi:https://doi.org/10.2337/dc09-1758
Effects of Exenatide and Lifestyle Modification on Body Weight and Glucose Tolerance in Obese Subjects With and Without Pre-Diabetes
Julio Rosenstock, MD; Leslie J. Klaff, MD, PHD; Sherwyn Schwartz, MD; Justin Northrup, MPT; John H. Holcombe, MD; Kenneth Wilhelm, MD; Michael Trautmann, MD
Diabetes Care March 2010, Vol.33, 1173-1175. doi:https://doi.org/10.2337/dc09-1203
A 24-Week, Randomized, Treat-to-Target Trial Comparing Initiation of Insulin Glargine Once-Daily With Insulin Detemir Twice-Daily in Patients With Type 2 Diabetes Inadequately Controlled on Oral Glucose-Lowering Drugs
Sanne G. Swinnen, MD; Marie-Paule Dain, MD; Ronnie Aronson, MD; Melanie Davies, MD; Hertzel C. Gerstein, MD; Andreas F. Pfeiffer, MD, PHD; Frank J. Snoek, PHD; J. Hans DeVries, MD, PHD; Joost B. Hoekstra, MD, PHD; Frits Holleman, MD, PHD
Diabetes Care March 2010, Vol.33, 1176-1178. doi:https://doi.org/10.2337/dc09-2294
Epidemiology / Health Services Research
Insulin Resistance Predicts Mortality in Nondiabetic Individuals in the U.S.
Diabetes Care March 2010, Vol.33, 1179-1185. doi:https://doi.org/10.2337/dc09-2110
Testosterone Concentrations in Diabetic and Nondiabetic Obese Men
Sandeep Dhindsa, MD; Michael G. Miller, PHARMD; Cecilia L. McWhirter, MS; Donald E. Mager, PHARMD, PHD; Husam Ghanim, PHD; Ajay Chaudhuri, MD; Paresh Dandona, MD
Diabetes Care March 2010, Vol.33, 1186-1192. doi:https://doi.org/10.2337/dc09-1649
Cost-Effectiveness of Aspirin Use Among Persons With Newly Diagnosed Type 2 Diabetes
Diabetes Care March 2010, Vol.33, 1193-1199. doi:https://doi.org/10.2337/dc09-1888
Educational Disparities in Mortality Among Adults With Diabetes in the U.S.
Diabetes Care March 2010, Vol.33, 1200-1205. doi:https://doi.org/10.2337/dc09-2094
Prediction of Type 1 Diabetes in the General Population
Mikael Knip, MD, PHD; Sari Korhonen, MD; Petri Kulmala, MD, PHD; Riitta Veijola, MD, PHD; Antti Reunanen, MD, PHD; Olli T. Raitakari, MD, PHD; Jorma Viikari, MD, PHD; Hans K. Åkerblom, MD, PHD
Diabetes Care June 2010, Vol.33, 1206-1212. doi:https://doi.org/10.2337/dc09-1040
Treatment of Type 2 Diabetes and Outcomes in Patients With Heart Failure: A Nested Case–Control Study From the U.K. General Practice Research Database
Michael R. MacDonald, MBCHB; Dean T. Eurich, PHD; Sumit R. Majumdar, MD, MPH; James D. Lewsey, BSC, PHD; Sai Bhagra, MBCHB; Pardeep S. Jhund, BSC, MBCHB, MSC; Mark C. Petrie, MBCHB; John J.V. McMurray, MD; John R. Petrie, MD; Finlay A. McAlister, MD, MSC
Diabetes Care June 2010, Vol.33, 1213-1218. doi:https://doi.org/10.2337/dc09-2227
Maternal Glucose at 28 Weeks of Gestation Is Not Associated With Obesity in 2-Year-Old Offspring: The Belfast Hyperglycemia and Adverse Pregnancy Outcome (HAPO) Family Study
David J. Pettitt, MD; Sonia McKenna, BSC; Ciara McLaughlin, MD; Christopher C. Patterson, PHD; David R. Hadden, MD; David R. McCance, MD
Diabetes Care March 2010, Vol.33, 1219-1223. doi:https://doi.org/10.2337/dc09-2384
The Risk of Overall Mortality in Patients With Type 2 Diabetes Receiving Glipizide, Glyburide, or Glimepiride Monotherapy: A retrospective analysis
Kevin M. Pantalone, DO; Michael W. Kattan, PHD; Changhong Yu, MS; Brian J. Wells, MD, MS; Susana Arrigain, MA; Anil Jain, MD; Ashish Atreja, MD, MPH; Robert S. Zimmerman, MD, FACE
Diabetes Care March 2010, Vol.33, 1224-1229. doi:https://doi.org/10.2337/dc10-0017
Association Between Glycemia, Serum Lipoproteins, and the Risk of Oral Leukoplakia: The population-based Study of Health in Pomerania (SHIP)
Peter Meisel, PHD; Michael Dau, MD; Wolfgang Sümnig, MD; Birte Holtfreter, PHD; Mohammad Houshmand, MD; Matthias Nauck, MD; Thomas Kocher, MD
Diabetes Care March 2010, Vol.33, 1230-1232. doi:https://doi.org/10.2337/dc09-1262
Transcription Factor 7-Like 2 (TCF7L2) Polymorphism and Hyperglycemia in an Adult Italian Population-Based Cohort
Roberto Gambino, PHD; Simona Bo, MD; Luigi Gentile, MD; Giovanni Musso, MD; Gianfranco Pagano, MD; Paolo Cavallo-Perin, MD; Maurizio Cassader, PHD
Diabetes Care March 2009, Vol.33, 1233-1235. doi:https://doi.org/10.2337/dc09-1690
Association of A1C Levels With Vitamin D Status in U.S. Adults: Data from the National Health and Nutrition Examination Survey
Jatupol Kositsawat, MD, DMSC, MPH; Vincent L. Freeman, MD, MPH; Ben S. Gerber, MD, MPH; Stephen Geraci, MD
Diabetes Care March 2010, Vol.33, 1236-1238. doi:https://doi.org/10.2337/dc09-2150
Parity, Breastfeeding, and the Subsequent Risk of Maternal Type 2 Diabetes
Diabetes Care March 2010, Vol.33, 1239-1241. doi:https://doi.org/10.2337/dc10-0347
Emerging Treatments and Technologies
Evaluation of an Algorithm to Guide Patients With Type 1 Diabetes Treated With Continuous Subcutaneous Insulin Infusion on How to Respond to Real-Time Continuous Glucose Levels: A randomized controlled trial
Alicia J. Jenkins, MD; Balasubramanium Krishnamurthy, MD; James D. Best, MD; Fergus J. Cameron, MD; Peter G. Colman, MD; Steven Farish, MED; Peter S. Hamblin, FRACP; Michele A. O'Connell, MRCPI; Christine Rodda, PHD; Kevin Rowley, PHD; Helena Teede, PHD; David N. O'Neal, MD
Diabetes Care March 2010, Vol.33, 1242-1248. doi:https://doi.org/10.2337/dc09-1481
Real-Time Hypoglycemia Prediction Suite Using Continuous Glucose Monitoring: A safety net for the artificial pancreas
Eyal Dassau, PHD; Fraser Cameron, MS; Hyunjin Lee, PHD; B. Wayne Bequette, PHD; Howard Zisser, MD; Lois Jovanovič, MD; H. Peter Chase, MD; Darrell M. Wilson, MD; Bruce A. Buckingham, MD; Francis J. Doyle, III, PHD
Diabetes Care June 2010, Vol.33, 1249-1254. doi:https://doi.org/10.2337/dc09-1487
DURATION-1: Exenatide Once Weekly Produces Sustained Glycemic Control and Weight Loss Over 52 Weeks
John B. Buse, MD, PHD; Daniel J. Drucker, MD; Kristin L. Taylor, PHD; Terri Kim, MS; Brandon Walsh, PHD; Hao Hu, MS; Ken Wilhelm, MD; Michael Trautmann, MD; Larry Z. Shen, PHD; Lisa E. Porter, MD; for the DURATION-1 Study Group
Diabetes Care March 2010, Vol.33, 1255-1261. doi:https://doi.org/10.2337/dc09-1914
Hyperglycemia-Induced Platelet Activation in Type 2 Diabetes Is Resistant to Aspirin but Not to a Nitric Oxide–Donating Agent
Paolo Gresele, MD, PHD; Stefania Marzotti, MD; Giuseppe Guglielmini, PHD; Stefania Momi, PHD; Silvia Giannini, PHD; Pietro Minuz, MD; Paola Lucidi, MD; Geremia B. Bolli, MD, PHD
Diabetes Care March 2010, Vol.33, 1262-1268. doi:https://doi.org/10.2337/dc09-2013
The Cost-Effectiveness of Continuous Glucose Monitoring in Type 1 Diabetes
Elbert S. Huang, MD, MPH; Michael O'Grady, PHD; Anirban Basu, PHD; Aaron Winn, MPP; Priya John, MPH; Joyce Lee, MD, MPH; David Meltzer, MD, PHD; Craig Kollman, PHD; Lori Laffel, MD, MPH; William Tamborlane, MD; Stuart Weinzimer, MD; Tim Wysocki, PHD; the Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group
Diabetes Care March 2010, Vol.33, 1269-1274. doi:https://doi.org/10.2337/dc09-2042
Online Diabetes Self-Management Program: A randomized study
Kate Lorig, RN, DRPH; Philip L. Ritter, PHD; Diana D. Laurent, MPH; Kathryn Plant, MPH; Maurice Green, PHD; Valarie Blue Bird Jernigan, PHD; Siobhan Case, BA
Diabetes Care March 2010, Vol.33, 1275-1281. doi:https://doi.org/10.2337/dc09-2153
Novel Use of Glucagon in a Closed-Loop System for Prevention of Hypoglycemia in Type 1 Diabetes
Jessica R. Castle, MD; Julia M. Engle, BA; Joseph El Youssef, MBBS; Ryan G. Massoud, BS; Kevin C.J. Yuen, MD; Ryland Kagan, BS; W. Kenneth Ward, MD
Diabetes Care March 2010, Vol.33, 1282-1287. doi:https://doi.org/10.2337/dc09-2254
Oral Insulin: A Comparison With Subcutaneous Regular Human Insulin in Patients With Type 2 Diabetes
Christoph Kapitza, MD; Eric Zijlstra, PHD; Lutz Heinemann, PHD; M. Cristina Castelli, PHD; Gary Riley, DVM, PHD; Tim Heise, MD
Diabetes Care February 2010, Vol.33, 1288-1290. doi:https://doi.org/10.2337/dc09-1807
Novel Assay of Metformin Levels in Patients With Type 2 Diabetes and Varying Levels of Renal Function: Clinical recommendations
Anders Frid, MD, PHD; Gunnar N. Sterner, MD, PHD; Magnus Löndahl, MD; Clara Wiklander, MD; Anne Cato, BS; Ellen Vinge, MD, PHD; Anders Andersson, PHD
Diabetes Care March 2010, Vol.33, 1291-1293. doi:https://doi.org/10.2337/dc09-1284
The Role of Adjunctive Exenatide Therapy in Pediatric Type 1 Diabetes
Vandana S. Raman, MD; Kimberly J. Mason, RN; Luisa M. Rodriguez, MD; Krishnavathana Hassan, MD; Xiaoying Yu, MS; Lisa Bomgaars, MD; Rubina A. Heptulla, MD
Diabetes Care March 2010, Vol.33, 1294-1296. doi:https://doi.org/10.2337/dc09-1959
Variation of Interstitial Glucose Measurements Assessed by Continuous Glucose Monitors in Healthy, Nondiabetic Individuals
Diabetes Care March 2010, Vol.33, 1297-1299. doi:https://doi.org/10.2337/dc09-1971
Switching to Once-Daily Liraglutide From Twice-Daily Exenatide Further Improves Glycemic Control in Patients With Type 2 Diabetes Using Oral Agents
John B. Buse, MD, PHD; Giorgio Sesti, MD; Wolfgang E. Schmidt, MD, PHD; Eduard Montanya, MD, PHD; Cheng-Tao Chang, PHD; Yizhen Xu, MD, PHD; Lawrence Blonde, MD; Julio Rosenstock, MD; for the Liraglutide Effect Action in Diabetes (LEAD)-6 Study Group
Diabetes Care March 2010, Vol.33, 1300-1303. doi:https://doi.org/10.2337/dc09-2260
Pathophysiology / Complications
Long-Term Metformin Use Is Associated With Decreased Risk of Breast Cancer
Michael Bodmer, MD; Christian Meier, MD; Stephan Krähenbühl, MD; Susan S. Jick, DSC; Christoph R. Meier, PHD
Diabetes Care March 2010, Vol.33, 1304-1308. doi:https://doi.org/10.2337/dc09-1791
Progression of Cerebral Atrophy and White Matter Hyperintensities in Patients With Type 2 Diabetes
Jeroen de Bresser, MD; Audrey M. Tiehuis, MD, PHD; Esther van den Berg, PHD; Yael D. Reijmer, MSC; Cynthia Jongen, PHD; L. Jaap Kappelle, MD, PHD; Willem P. Mali, MD, PHD; Max A. Viergever, PHD; Geert Jan Biessels, MD, PHD; on behalf of the Utrecht Diabetic Encephalopathy Study Group
Diabetes Care March 2010, Vol.33, 1309-1314. doi:https://doi.org/10.2337/dc09-1923
Urinary Liver-Type Fatty Acid-Binding Protein Predicts Progression to Nephropathy in Type 1 Diabetic Patients
Stine Elkjaer Nielsen, MD; Takeshi Sugaya, MD, PHD; Peter Hovind, MD, DMSC; Tsuneharu Baba, MD, PHD; Hans-Henrik Parving, MD, DMSC; Peter Rossing, MD, DMSC
Diabetes Care February 2010, Vol.33, 1320-1324. doi:https://doi.org/10.2337/dc09-2242
Explanations for the Lower Rates of Diabetic Neuropathy in Indian Asians Versus Europeans
Caroline A. Abbott, PHD; Nishi Chaturvedi, MD; Rayaz A. Malik, PHD; Eleanna Salgami, MD; Allen P. Yates, PHD; Philip W. Pemberton, PHD; Andrew J.M. Boulton, MD
Diabetes Care March 2010, Vol.33, 1325-1330. doi:https://doi.org/10.2337/dc09-2067
Alterations in Retinal Microvascular Geometry in Young Type 1 Diabetes
Muhammad Bayu Sasongko, MD, MEPI; Jie Jin Wang, MMED, PHD; Kim C. Donaghue, FRACP, PHD; Ning Cheung, MBBS; Paul Benitez-Aguirre, BSC, MBBS, MPH; Alicia Jenkins, MBBS, MD; Wynne Hsu, PHD; Mong-Li Lee, PHD; Tien Y. Wong, MD, PHD
Diabetes Care March 2010, Vol.33, 1331-1336. doi:https://doi.org/10.2337/dc10-0055
High-Normal Serum Uric Acid Increases Risk of Early Progressive Renal Function Loss in Type 1 Diabetes: Results of a 6-year follow-up
Linda H. Ficociello, DSC; Elizabeth T. Rosolowsky, MD, MPH; Monika A. Niewczas, MD, PHD; Nicholas J. Maselli, BA; Janice M. Weinberg, SCD; Ann Aschengrau, SCD; John H. Eckfeldt, MD, PHD; Robert C. Stanton, MD; Andrzej T. Galecki, MD, PHD; Alessandro Doria, MD, PHD, MPH; James H. Warram, MD, SCD; Andrzej S. Krolewski, MD, PHD
Diabetes Care March 2010, Vol.33, 1337-1343. doi:https://doi.org/10.2337/dc10-0227
Renal Hyperfiltration Is a Determinant of Endothelial Function Responses to Cyclooxygenase 2 Inhibition in Type 1 Diabetes
David Z.I. Cherney, MD, CM, PHD; Judith A. Miller, MD, MSC, MHSC; James W. Scholey, MD; Rania Nasrallah, PHD; Richard L. Hébert, PHD; Maria G. Dekker, RN; Cameron Slorach, RDCS; Etienne B. Sochett, MBCHB; Timothy J. Bradley, MBCHB
Diabetes Care March 2010, Vol.33, 1344-1346. doi:https://doi.org/10.2337/dc09-2340
Cardiovascular and Metabolic Risk
Derivation and Validation of a New Cardiovascular Risk Score for People With Type 2 Diabetes: The New Zealand Diabetes Cohort Study
C. Raina Elley, MBCHB, PHD; Elizabeth Robinson, MSC; Tim Kenealy, MBCHB, PHD; Dale Bramley, MBCHB, MPH; Paul L. Drury, MA, MB, BCHIR
Diabetes Care March 2010, Vol.33, 1347-1352. doi:https://doi.org/10.2337/dc09-1444
Long-Term Trends in Cardiorespiratory Fitness and the Incidence of Type 2 Diabetes
Susumu S. Sawada, PHD; I.-Min Lee, MD, SCD; Hisashi Naito, PHD; Jun Noguchi, MD, PHD; Koji Tsukamoto, MD, PHD; Takashi Muto, MD, PHD; Yasuki Higaki, PHD; Hiroaki Tanaka, PHD; Steven N. Blair, PED
Diabetes Care March 2010, Vol.33, 1353-1357. doi:https://doi.org/10.2337/dc09-1654
Prognostic Value of Coronary Computed Tomographic Angiography in Diabetic Patients Without Known Coronary Artery Disease
Martin Hadamitzky, MD; Franziska Hein, MD; Tanja Meyer, MD; Bernhard Bischoff, MD; Stefan Martinoff, MD; Albert Schömig, MD; Jörg Hausleiter, MD
Diabetes Care March 2010, Vol.33, 1358-1363. doi:https://doi.org/10.2337/dc09-2104
Childhood Size and Life Course Weight Characteristics in Association With the Risk of Incident Type 2 Diabetes
Edwina H. Yeung, PHD; Cuilin Zhang, MD, PHD; Germaine M. Buck Louis, PHD; Walter C. Willett, MD, DRPH; Frank B. Hu, MD, PHD
Diabetes Care March 2010, Vol.33, 1364-1369. doi:https://doi.org/10.2337/dc10-0100
Validity of a Single-Factor Model Underlying the Metabolic Syndrome in Children: A confirmatory factor analysis
Vicente Martínez-Vizcaíno, MD; Montserrat Solera Martínez, MSTAT; Fernando Salcedo Aguilar, MD; Sandra Serrano Martínez, MD; Ricardo Franquelo Gutiérrez, MD; Mairena Sánchez López, PHD; Pablo Moya Martínez, MD; Fernando Rodríguez-Artalejo, MD
Diabetes Care March 2010, Vol.33, 1370-1372. doi:https://doi.org/10.2337/dc09-2049
Serum 25-Hydroxy Vitamin D and Insulin Resistance, Metabolic Syndrome, and Glucose Intolerance Among Arab Americans
Nicole R. Pinelli, PHARMD, MS, CDE; Linda A. Jaber, PHARMD; Morton B. Brown, PHD; William H. Herman, MD, MPH
Diabetes Care March 2010, Vol.33, 1373-1375. doi:https://doi.org/10.2337/dc09-2199
Independent Metabolic Syndrome Variants Predict New-Onset Coronary Artery Disease
Dhananjay Vaidya, PHD; Rasika A. Mathias, PHD; Brian G. Kral, MD; Lisa R. Yanek, MS; Lewis C. Becker, MD; Diane M. Becker, SCD
Diabetes Care March 2010, Vol.33, 1376-1378. doi:https://doi.org/10.2337/dc09-2211
Association of Vitamin D With Insulin Resistance and β-Cell Dysfunction in Subjects at Risk for Type 2 Diabetes
Sheena Kayaniyil, MSC; Reinhold Vieth, PHD; Ravi Retnakaran, MD; Julia A. Knight, PHD; Ying Qi, MSC; Hertzel C. Gerstein, MD; Bruce A. Perkins, MD; Stewart B. Harris, MD; Bernard Zinman, MD; Anthony J. Hanley, PHD
Diabetes Care March 2010, Vol.33, 1379-1381. doi:https://doi.org/10.2337/dc09-2321
Glucose Intolerance and Cardiometabolic Risk in Adolescents Exposed to Maternal Gestational Diabetes: A 15-year follow-up study
Wing Hung Tam, FRCOG; Ronald Ching Wan Ma, MRCP; Xilin Yang, PHD; Albert Martin Li, MD; Gary Tin Choi Ko, MD; Alice Pik Shan Kong, FRCP; Terence Tzu Hsi Lao, MD; Michael Ho Ming Chan, FRCPA; Christopher Wai Kei Lam, PHD; Juliana Chung Ngor Chan, MD
Diabetes Care March 2010, Vol.33, 1382-1384. doi:https://doi.org/10.2337/dc09-2343
Optimal Definitions for Abdominal Obesity and the Metabolic Syndrome in Andean Hispanics: The PREVENCION Study
Josefina Medina-Lezama, MD; Catherine A. Pastorius, BA; Humberto Zea-Diaz, MD, MPH; Antonio Bernabe-Ortiz, MD, MPH; Fernando Corrales-Medina, MD; Oscar Leopoldo Morey-Vargas, MD; Diana Andrea Chirinos, BPSYCH; Edgar Muñoz-Atahualpa, MD; Julio Chirinos-Pacheco, MD, PHD; Julio Alonso Chirinos, MD; on behalf of the PREVENCION Investigators
Diabetes Care March 2010, Vol.33, 1385-1388. doi:https://doi.org/10.2337/dc09-2353
Original Article
Age at Onset and the Risk of Proliferative Retinopathy in Type 1 Diabetes
Kustaa Hletala, MD; Valma Harjutsalo, PHD; Carol Forsblom, DMSC; Paula summanen, MD; Per-Henrik Groop, MD; on behalf of the flnndlane study Group
Diabetes Care February 2010, Vol.33, 1315-1319. doi:https://doi.org/10.2337/dc09-2278
Reviews / Commentaries / ADA Statements
Reviews
Hypoglycemia, Diabetes, and Cardiovascular Events
Diabetes Care June 2010, Vol.33, 1389-1394. doi:https://doi.org/10.2337/dc09-2082
Position Statement
Aspirin for Primary Prevention of Cardiovascular Events in People With Diabetes: A position statement of the American Diabetes Association, a scientific statement of the American Heart Association, and an expert consensus document of the American College of Cardiology Foundation
Michael Pignone, MD, MPH, FACP; Mark J. Alberts, MD; John A. Colwell, MD, PHD, MACP; Mary Cushman, MD, MSC; Silvio E. Inzucchi, MD; Debabrata Mukherjee, MD, MS, FACC; Robert S. Rosenson, MD, FACC, FAHA, FACP; Craig D. Williams, PHARMD, FNLA; Peter W. Wilson, MD; M. Sue Kirkman, MD
Diabetes Care June 2010, Vol.33, 1395-1402. doi:https://doi.org/10.2337/dc10-0555
Editorials
Enhancing the Understanding of Pre-Type 1 Diabetes in the General Population
Diabetes Care June 2010, Vol.33, 1403-1405. doi:https://doi.org/10.2337/dc10-0566
Erratum
Perspectives on the News
Neuropathy, Retinopathy, and Glucose-Lowering Treatments
Diabetes Care June 2010, Vol.33, e73-e78. doi:https://doi.org/10.2337/dc10-zb06
Online Letters: Observations
Relationship Between Glycated Hemoglobin and Metabolic Syndrome of Type 1 and Type 2 Diabetes: A factor analysis study
Fernando M.A. Giuffrida, MD, PHD; Celso F.C. Sallum, MD; Monica A.L. Gabbay, MD, MSC; Marilia B. Gomes, MD, PHD; Antonio C. Pires, MD, PHD; Sergio A. Dib, MD, PHD
Diabetes Care June 2010, Vol.33, e80. doi:https://doi.org/10.2337/dc09-2280
Continuous Subcutaneous Insulin Infusion Is Better Than Multiple Daily Insulin Injections in Reducing Glucose Variability Only in Type 1 Diabetes With Good Metabolic Control
Giuseppe Lepore, MD; Anna Corsi, MD; Alessandro R. Dodesini, MD; Italo Nosari, MD; Roberto Trevisan, MD, PHD
Diabetes Care June 2010, Vol.33, e81. doi:https://doi.org/10.2337/dc10-0355
Improved Glycemic Control With the Multi-Receptor Tyrosine Kinase Inhibitor Pazopanib
Diabetes Care June 2010, Vol.33, e82. doi:https://doi.org/10.2337/dc10-0436
Online Letters: Comments and Responses
Insulin Assay Standardization: Leading to Measures of Insulin Sensitivity and Secretion for Practical Clinical Care: Response to Heinemann
Myrlene A. Staten, MD; W. Greg Miller, PHD; Ronald R. Bowsher, PHD; Michael W. Steffes, MD, PHD; for the Insulin Standardization Workgroup
Diabetes Care June 2010, Vol.33, e84. doi:https://doi.org/10.2337/dc10-0478
